SCHEMBL24814437

SCHEMBL24814437

Cc1nnc(SCC(=O)N2Cc3ccccc3C2)s1

nearest known ligand 0.84

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.65
▸ MAPT P10636 4/20 0.65
▸ GAA P10253 3/20 0.61
▸ L3MBTL1 Q9Y468 2/20 0.61
▸ SMN1; SMN2 Q16637 3/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ HTT P42858 3/20 0.57
▸ PKM P14618 2/20 0.56
▸ POLB P06746 2/20 0.55
▸ TSHR P16473 1/20 0.54
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ LMNA P02545 5/20 0.51
▸ NPSR1 Q6W5P4 3/20 0.51
▸ HSD11B1 P28845 2/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ NOD2 Q9HC29 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987226 1.00 ALDH1A1 (0.65) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL24816151 0.84 ATM (0.64) ALDH1A1MAPTGAASMN1; SMN2PKM
SCHEMBL29986879 0.84 ATM (0.64) ALDH1A1MAPTGAASMN1; SMN2PKM
SCHEMBL29986865 0.81 ALDH1A1 (0.53) ALDH1A1MAPTGAASMN1; SMN2KDM4E
SCHEMBL24814748 0.81 ALDH1A1 (0.53) ALDH1A1MAPTGAASMN1; SMN2KDM4E
SCHEMBL29986787 0.81 ALDH1A1 (0.48) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL24815794 0.81 ALDH1A1 (0.48) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL24814434 0.75 ALDH1A1 (0.47) ALDH1A1MAPTGAASMN1; SMN2KDM4E
SCHEMBL29986261 0.75 ALDH1A1 (0.47) ALDH1A1MAPTGAASMN1; SMN2KDM4E
SCHEMBL24815859 0.73 RAB9A (0.61) ALDH1A1MAPTSMN1; SMN2KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH ALDH1A1 3533/4885MAPT 4407/4885GAA 2875/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH ALDH1A1 3533/4885MAPT 4407/4885GAA 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback